COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 8 of 12 for:    Arimoclomol

Study of Arimoclomol in Inclusion Body Myositis (IBM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02753530
Recruitment Status : Active, not recruiting
First Posted : April 28, 2016
Last Update Posted : November 10, 2020
University of Kansas Medical Center
University College, London
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2021
Estimated Study Completion Date : February 2021